DKSH and Grünenthal expand Asia-Pacific pain treatment partnership

DKSH will support commercialization of four Grünenthal products in up to eight Asia-Pacific markets, including Hong Kong, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand and Vietnam. The agreement expands an existing partnership that previously covered three medicines.